Analyses of the relationships between different viruses and viral proteins have focused on homologies between linear amino acid sequences, but cross-reactivities at the level of T cell recognition may not be dependent on a conserved linear sequence of several amino acids. The CTL response to Pichinde virus (PC) and vaccinia virus (VV) in C57BL/6 mice previously immunized with lymphocytic choriomeningitis virus (LCMV) included the reactivation of memory cytotoxic T lymphocyte (CTL) specific to LCMV. Limiting dilution assays (LDA) demonstrated that at least part of this reactivation of memory cells in LCMV-immune mice related to cross-reactivity at the clonal level, even though acute infections with these viruses in nonimmune mice elicited CTL responses that did not cross-react in conventional bulk CTL assays. Precursor CTL (pCTL) to LCMV were generated in splenic leukocytes from LCMV-immune mice acutely infected with PV or W when stimulated in vitro with only the second virus but not with uninfected peritoneal exudate cells (PECs). Cytotoxicity mediated by l.CMV-specific CTL clones activated by PV infection was greatly inhibited by anti-CD8 antibody, suggesting that these memory CTL clones recognizing LCMV-infected targets were of low affinity. LCMV-immune splenocytes stimulated in vitro with FV or W demonstrated a low but significant precursor frequency (p/f) to the heterologous viruses, and splenocytes from PV-or W-immune mice when stimulated in vitro against I_CMV generated a low but significant p/f to LCMV. Short-term CTL dones cross-reactive between LCMV and FV were derived from splenic leukocytes from LCMV-immune mice acutely infected with PV. To distinguish whether the cross-reactivity was directed against a viral peptide or a virus-induced endogenous cellular neoantigen, we demonstrated that a pCTL frequency to PV about 1/4-1/7 that of the frequency to LCMV could be generated from LCMV-immune splenic leukocytes stimulated with the immunodominant LCMV NP peptide. A partially homologous PV peptide generated from the equivalent site to the LCMV NP peptide did not sensitize targets to lysis by either LCMV-or PV-specific CTLs, suggesting that the cross-reactivity in killing was not due to evolutionarily conserved equivalent sequences. Experiments also indicated that prior immunity to one virus could modulate future primary immune responses to a second virus. Elevated pCTL frequencies to PV were seen after acute FV infection of LCMV-immune mice, and elevated pCTL frequencies to LCMV were seen after acute LCMV infection of PV-and W-immune mice. The implication of these analyses is that, at the T cell level, there may be a great deal of immunological cross-reactivity between heterologous viruses, and by virtue of this proposed remote T cell crossreactivity, the host's response to a virus infection may be modified by its previous experience with other putatively unrelated pathogens. nalyses of the relationships between viruses have focused on homologies in nucleotide or amino acid sequences. Sharing of a linear sequence of amino acids between different viral proteins can result in serological cross-reactivities, leading to cross-protective immunity. Selective pressure at the level of viral neutralization has led to high variation of virion surface proteins between virus species, and it is this lack of crossreactivity at the level of neutralizing antibodies that is used as a major criterion for identifying distinct virus species. Crossreactivities at the level of T cell recognition may be altogether different and much less dependent on a conserved linear sequence of several amino acids. Some studies analyzing immunodominant epitopes of infectious agents have found that apparently unrelated peptides from the same or a heterolognus virus can sensitize a target cell to the same CTL line or clone (1-4). Analyses of the amino acid sequences of these peptides have shown relatively little amino acid homology, with the exception that the peptides needed to comply with
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nalyses of the relationships between viruses have focused on homologies in nucleotide or amino acid sequences. Sharing of a linear sequence of amino acids between different viral proteins can result in serological cross-reactivities, leading to cross-protective immunity. Selective pressure at the level of viral neutralization has led to high variation of virion surface proteins between virus species, and it is this lack of crossreactivity at the level of neutralizing antibodies that is used as a major criterion for identifying distinct virus species. Crossreactivities at the level of T cell recognition may be altogether different and much less dependent on a conserved linear sequence of several amino acids. Some studies analyzing immunodominant epitopes of infectious agents have found that apparently unrelated peptides from the same or a heterolognus virus can sensitize a target cell to the same CTL line or clone (1) (2) (3) (4) . Analyses of the amino acid sequences of these peptides have shown relatively little amino acid homology, with the exception that the peptides needed to comply with the sequence motif for the presenting MHC molecule and therefore sometimes shared identical amino acids in two or three positions of the peptide nonamer (5) . The implication of these analyses is that, at the T cell level, there may be a great deal of immunological cross-reactivity between serologically distinct viruses.
We have been analyzing the specificities and cross-reactixa'ties of CTL induced in mice by LCMV, which elicits a profound polyclonal CD8 + CTL response associated with a 10-40-fold increase in total number of activated proliferating CD8 + T cells/spleen (6) . The vast majority of these cells display activation markers such as the IL-2R (CD25) (7), the memory cell marker Pgp-1 (CD44) (8) and the adhesion molecule and memory marker Mac-1 (CDllb) (9) , and at least 25% of the cells have the large granular lymphocyte morphology of cytotoxic effectors (10) . Part of the CTL response consists of allospecific CTL detectable in primary bulk assays and specific for cells expressing a wide variety of alloantigens (6, 11, 12) . Limiting dilution assay (LDA) 1 analyses demonstrated many aUospecific CTL dones cross-reactive with virusinfected syngeneic targets. This induction of allospecific CTL also occurred in mouse infections with vaccinia virus (VV), Pinchinde virus (PV), and murine cytomegalovirus (MCMV) (11, 12) , and in the human during acute EBV infection (13, 14) .
A second observation was that in lymphocytic choriomenigitis virus (LCMV)-hyperimmune mice, i.e., mice challenged with I.CMV one to two times after original infection, a portion of the CTL response elicited during acute infection with a second virus (PV, VV, or MCMV) consisted of memory CTLs specific for the first virus, LCMV (12) . The present study demonstrates that these LCMV-specific CTLs are easily detectable in mice having received a single LCMV infection and later challenged with a heterologous viral infection (PV, VV). Analogous to the allospecific CTL at the donal level, an unexpectedly large portion of these LCMV-specific CTLs were cross-reactive with MHC-syngeneic target cells infected with the second virus. In addition, a history of LCMV infection caused a more vigorous CTL response to either PV or VV.
This study demonstrates that there may be much greater than anticipated immunological cross-reactivity at the T cell level between viruses that are serologically unrelated and that such cross-reactivity may be of significance in one's "natural" resistance to subsequent infections with unrelated viruses.
Mat~riah and Methods
M/ce. The C57BL/6 (H-2 b) mice were purchased from The Jackson Laboratories (Bar Harbor, ME). Mice were used at 1-6 mo of age, Viruses. The LCMV Armstrong strain was propagated in BHK21 baby hamster kidney cells (15) . The WK strain of W and the AN3739 strain of IN, an arenavirus only distantly related to LCMV, were propagated in L929 cells (16) . Mice were injected in-1 Abbreviations used in this paper: LCMV, lymphocytic choriomeningitis virus; LDA, limiting dilution assay; MCMV, routine cytomegalovirus; NP, nucleoprotein; pCTL, precursor CTL; PEC, peritoneal exudate cell; p/f, precursor frequency; PV, Pichinde virus; VV, vacdnia virus. traperitoneally with 4 x 104 PFU of LCMV, 7 x 106 PFU of W, or 106 PFU of PV in 0.1 ml vol/mouse for acute virus infection.
Cell Lines. KO cells (H-2b), a SV40-transformed kidney cell line derived from a C57BL/6 mouse (17) and provided to us by Dr. Satvir Tevethia (Pennsylvania State Medical Center, Hershey, PA), were propagated in DMEM (Gibco Laboratories, Grand Island, NY) supphmented with 100 U/m1 penidllin G, 100 #g/m1 streptomycin sulfate, 2 mM L-glutamine, 5 • 10-s M 2-ME, 10 mM Hepes, and 10% heat inactivated (56~ 30 rain) FBS (Sigma Chemical Co., St. Louis, MO). L929 (H-2~), a continuous liver cell line derived from C3H mice, and MC57G (H-2b), a methylcholanthrene-induced fibrobhst cell line from C57BL/6 mice, were propagated in Eagle's MEM (Gibco Laboratories) supplemented with 100 U/m1 penicillin G, 100 #g/m1 streptomycin sulfate, 2 mM L-glutamine, and 10% heat inactivated FBS. KO and MC57G cells were infected with LCMV or IN at a multiplicity ofinfi~on (MOI) of 0.1-0.2 PFU/cell and incubated for 2 d at 37~ KO ceils were infected with W at a MOI of 4 for 3-4 h at 37~
Depletion of NK Cells In Vim. Antiserum to asialo GM1 (5 #1; Wako Chemical, Dallas, TX) was injected intraperitoneally in a volume of 0.1 ml, on days 0 and 4 of acute infection. In immune mice not receiving a second viral infection, the antibody was given 2 d before the harvesting of spleens. As the asialo GMI antigen can be expressed on some T cells (18, 19) , we carefully titrated every lot to obtain a concentration of antiserum that selectively reduces NK cell activity without affecting CTL activity. This regimen of antibody nearly completely depleted NK cell activity for at least an 8-d time period.
Cytotoxicity Assays. Ceil-mediated cytotoxicity was determined using a standard microcytotoxidty (CTL) assay (16) . KO cells (1-3 x 106) were pelleted, resuspended in 0.2 ml of Na-SlCr (Amersham Corp., Arlington Heights, IL), and incubated for 1 h at 37~ in a humidified 5% COs incubator. They were rinsed three times and resuspended to 5 x 10~/ml, and 0.1 ml was added to roundbottomed microtiter wells (Falcon Labware, Oxnard, CA). Varying numbers of effector leukocytes were added in triplicate in 0.1 ml of medium to achieve the desired E/T ratio. For spontaneous SlCr release controls, 0.1 ml of media was added to the labeled target cells in place of effectors. For maximum SlCr-release control, 0.1 ml ofi% NP-40 (United States Biochemical Co., Cleveland, OH) was added to the labeled target cells. After 6-8 h at 37~ in a 5% COs incubator, the microtiter plates were centrifuged at 200 g for 5 min. Supematant was removed (0.1 ml) from each well and counted on a gamma counter (model 5000; Beckman Instruments, Inc., Fullerton, CA). Data are expressed as percent spedfic SlCr release = 100 x [(experimental cpm -spontaneous cpm)/(maximum release cpm -spontaneous release cpm)].
LDAfor Virus-specific CTL Precursors. The assays used the procedure of Moskophidis et al. (20) with modifications as previously described (6) . Briefly, splenic lymphocytes were harvested, titrated in U-96-weU plates with 24 replicates at each tritration. They were stimulated with virus infected peritoneal exudate cells (PECs) (3 x 104/well), supplemented with irradiated splenic feeders (1-2 x 10 s/well) and growth factors provided by using a 16% culture supernatant from the IL-2-secreting, gibbon lymphoma tumor cell line MLA.144 (American Type Culture Collection, Rockville, MD) (21) . These studies were routinely done with splenocytes isohted from mice depleted of NK cells by antiserum to asialo GM1 in order to minimize NK ceil outgrowth in the LDA. This treatment did not significantly alter the frequency of the LCMV-specific CTL precursors. In our earlier report we showed that the LCMV-specific CTL precursors were CD8 + ceils (6) .
In the case of W, which was a highly lytic virus in vitro, an alternate method was used. The thioglycollate-injected mice were also injected with 7 x 106 PFU of VV in 0.1 ml i.p. 12 h before plating. The isolated PEC were then plated at 3 x 104 cells/well in 50/xl of media, and neutralizing polyclonal rabbit antiserum to W was added at 1/50 dilution final concentration (22) . On days 5-8 of culture, individual wells were split threefold and assayed for cytolytic function on infected and uninfected syngeneic target cells (KO) using a modified stCr release assay. SlCr-labeled targets (5 x 103) were added to all wells to a final volume of 200 /~l/well. The plates were incubated 9-10 h at 37~ in a 5% CO2 incubator, centrifuged for 5 min at 130 g (IEC C1LU-5000 centrifuge; International Equipment Co., Needham Heights, MA), and 0.1 ml of supernatant was harvested. Positive wells were defined as those wells whose S:Cr release exceeded the mean spontaneous release by >3 SD. All wells that lysed uninfected syngeneic targets tested were eliminated from the analysis. Frequencies were calculated using X 2 analysis according to Taswell 
Anti-CD8 Blocking and Complement Depletion of CTL. Anti-
CD8 produced by hybridoma M12/7.2, well-documented to block CTL-mediated lysis, was kindly provided by Dr. Eric Martz (University of Massachusetts, Amherst, MA) (6). A 1:160 final dilution of an NH4SO4 cut of the hybridoma culture fluid was added to the LDA effector cells for I h before adding the targets on the day of the cytotoxicity assay. Splenocytes were depleted of CD8 § cells with antibody and rabbit complement as previously described (12).
NP-peptide Stimulation in LDAs. LCMV H-2 b restricted im-
munodominant nudeoprotein (NP) peptide (QPQNGQFIHFY) (5) was synthesized by Dr. Robert Carraway (University of Massachusetts Medical Center). These peptides were purified to >95% homogeneity by reverse-phase HPI.C. LDAs were set up as described above with the following exceptions: PECs were pulsed for 0.5 h with the peptide at 100 ~tM concentration and then placed in the LDA (100/~l/well). All media used in the LDA were the same as above except that they contained IL-7 (Genzyme Corp., Cambridge, MA) at 15 U/ml.
Results

Viral Infections Activate CTL Specific for Viruses from Previous
Infections. C57BL/6 mice were inoculated with LCMV to generate a pool of LCMV-specific memory T cells and used in experiments 1-4 mo later. These are referred to as LCMVimmune mice. As can be seen in Figs. 1 (day 5 post infection) and 2 (day 7 post acute infection), spleen leukocytes from uninfected control or from LCMV-immune mice failed to lyse significantly any of the targets tested, indicating that LCMV-specific CTLs are not detectable in the LCMV-immune mice in bulk CTL assays with freshly isolated lymphocytes. Acute inf~ion of C57BL/6 mice (depleted of NK cells) with LCMV, VV, or PV resulted in the generation of cytotoxicity specific for the infecting virus. The level of cytotoxic activity was low at day 5 for LCMV and PV and reached high levels at day 7, whereas the level of cytotoxic activity for VV peaked earlier at day 5. The CTLs induced by each virus were virusspecific and lysed cells infected with different viruses only at very low levels and comparable to uninfected targets. However, infection of LCMV-immune mice with W or PV stimulated both challenge virus-specific and LCMV-specific killing.
In previous experiments, we showed that the phenotype of the virus-specific killer cells activated by VV or PV infection of LCMV-hyperimmuue mice were CD8 +, Thyl.2 +, asialo GM1-T cells (12) . This indicated that memory CTL reactive against viral antigens from a previous heterologous viral infection were stimulated. These LCMV-spedfic CTLs appeared by day 5 (Fig. 1 ) post infection and persisted at day 7 (Fig. 2) .
Limiting Dilution Analysis of Spleen Leukocytes from LCMVimmune Mice Infected with a Second Virus. LDAs were performed in order to determine at the donal level if this reactivation of memory CTLs to the first viral infection could relate to possible remote cross-reactivities between the viruses. At day 7 after infection with FV, a splenic leukocyte precursor frequency (p/f) of 1/329 was derived against PV-infected target cells (Fig. 3 A) . This value is in the same range as those obtained for LCMV precursor (p)CTL at day 7 post LCMV infection (6) . During an acute PV infection pCTL against LCMV-infected targets were not detected (p/f <1/100,000) when leukocytes were stimulated in vitro against PV (Fig.  3 A) . However, in an LCMV-immune mouse acutely infected with PV for 7 d, splenic leukocytes stimulated with PV in vitro generated a p/f not only for PV-infected targets (1/212) but also for LCMV-infected targets (1/7636) (Fig. 3 B) . This was a consistent observation both at days 5 and 7 during an acute PV infection in an LCMV-immune mouse (Fig. 4, A and B) . As expected at day 5 of an acute PV infection, before the peak in PV-specific bulk CTL activity, the p/f for PV-infected targets was lower (1/1509) than at day 7 (11280), which is near the peak of CTL activity. This is the first time to our knowledge that p/s for PV infection have been described, and although the mouse is not a normal host for PV it did generate p/f's very similar to those previously observed for LCMV (6). The ratio of the p/f between PV and LCMV (stimulated against PV) was 1:3 at day 5 and 1:14 at day 7, suggesting a selection for the non-cross-reactive PV-specific CTL as the PV infection progressed.
I.CMV and PV are both arenaviruses and share some amino acid homology, but they can be considered beterologous viruses because their immunological cross-reactivity is quite remote (12, 24-26 whether the same clone of T ceils was recognizing targets infected with either of two viruses, LDAs were set up to produce a large number of wells statistically containing <0.5 pCTL/well for either LCMV-or W-infected targets (i.e., monodonal wells). In these studies, as in Figs. 3 and 4, LCMVimmune mice were acutely infected with IV, and CTL clones were generated in LDA from spleen leukocytes stimulated against IV-infected PEC. Thus, the arising LCMV-specific clones should be cross-reactive with PC, as they were cuhirated with a PV stimulus. Statistical analyses by 2-tail Fisher's Exact Test in five different experiments demonstrated that the wells containing effector cells lyric to targets infected with each virus were not due to random associations of distinct Iv-specific and LCMV-specific clones in the same well (Table  1) . This indicates that the same CTL done lysed both targets. At day 5 of the acute PV infection, "~23% (range 15-31%) of the wells containing Iv-specific pCTL clones were crossreactive with LCMV at the level of cytotoxicity, lysing both PV-and LCMV-infected targets. Approximately 62% (range 38-83%) of the wens containing LCMV-specific pCTL clones stimulated with PV-infected PEC were cytolytically crossreactive with PV, lysing both Iv-infected and LCMV-infected * C57BL mice were inoculated intraperitoneally with LCMV. 1-2 mo later these immune mice were inoculated with PC. At 5 (Expts. 1-4) to 7 (Expt. 5) d post infection spleen leukocytes from these mice were stimulated in vitro in LDA with PV-infected PECs, as described in Materials and Methods. * These data represent LDA wells with ~0.5 pCTL/well for both LCMV-and PV-infected targets when screened for CTL activity in a 10-h slCr release assay. S Statistical analysis of the distribution of clones by 2-tail Fisher's Exact test demonstrated the probability that the cross-reactive wells were not a random association of separate PV-specific and LCMV-specific clones. targets. However, a significant number of clones (38%) in each of these experiments lysed only the LCMV-infected targets. This is an unexpected observation, since these clones were stimulated to grow by FV-infected PEC. This observation could be explained by affinity differences or ff the crossreactive stringency for induction of proliferation of the memory l.CMV-specific pCTL is lower than that for target recognition and lysis. Alternatively, differences in antigen presentation (6, 27) or adhesion molecules (28, 29) between the stimulating PEC and the CTL assay targets (KO cells) might account for clones cytolytically specific only for LCMV.
Cross-reactive pCTL Elicited from Immune Mice Infected with Only One Virus. We questioned whether cross-reactive CTL could be generated from splenocytes of immune mice which had not been challenged in vivo with a second virus. Splenocytes from LCMV-immune mice not receiving acute PV infection when stimulated in vitro with heterologous virus (PV) generated p/f's to both LCMV-(1/135,000) and PV-infected (1/81,600) targets (Table 2) . PV-immune splenocytes stimuhted in vitro with the heterologous virus, LCMV, also generated p/fs to both targets (LCMV-infected targets, 1/473,000; PV-infected targets, 1/377,000) but at a lower level than observed with the I.CMV-immune splenocytes. VV-immune splenocytes when stimulated with LCMV in vitro generated pCTL to both I,CMV-and VV-infected targets, but the p/f curves were nonlinear (estimated p/f's: LCMV-infected targets, 1/341,000; VV-infected targets, 1/177,000) (not tabulated).
Splenocytes from an LCMV-immune mouse when stimulated in vitro with homologous LCMV generated a low but consistent p/f to PC-infected targets (1/13,000; 1/30,000) ( Table 2) . A similar observation ofpCTL to LCMV-irrfected targets was made with PC-immune (1/104,000) and VVimmune (1/321,000) (not tabulated) animals, as they were able to generate a low p/f to LCMV-infected targets when stimulated in vitro with the initial infecting virus. It should be noted that the p/f for LCMV-and FV-immune mice stimuhted with uninfected PECs or for unin~ted naive mice stimulated with I.CMV-or PV-infected PECs was <1/106.
pCTL in LCMV-immune Splenoo/tes Stimulated In Vitro with
LCMV NP Pept/d~ To determine whether the cross-reactivity between virus-infected cells was due to recognition of viral peptides, as opposed to a common virus-induced cellular antigen, we examined the p/f to LCMV-and PV-infected targets using LCMV-immune splenocytes stimulated in vitro with LCMV NP peptide. These experiments were done in the presence of IL-7, as this cytokine has recently been demonstrated to enhance the stimulation of virus-specific CTL by peptide alone in naive uninfected mice (30, 31) . Under these conditions, not only was an appropriate p/f to LCMV-infected targets (1/10,000; 1/24,000) generated but also a significant p/f to w-infected targets (1/71,000; 1/100,000) (Fig. 7) . NPspecific CTL compose ,x,20% of the pCTL to LCMV in an LCMV-immune C57BL/6 mouse. The usual LCMV p/f in an LCMV-immune C57BL/6 mouse is in our experimental system 1/1000-1/2000. Therefore, an LCMV-specific p/f of 1/10,000-1/20,000 would be appropriate in an LCMVimmune C57BL/6 mouse stimulated with NP peptide. Although 1/71,000 (1/100,000) is a low p/f, it is nonethdess significant, as stimulation of naive uninfected mice or LCMVimmune mice with uninfected PECs resulted in p/f's to either LCMV-or FV-infected targets of <1/10 ~. These results support the concept that viral peptides are involved in the recognition process by cross-reactive T cells between different viruses. with nonimmune mice when splenic leukocytes were stimulated in vitro with PV (Table 3) . Similarly, in individual experiments higher pCTL to LCMV were generated after LCMV infection of PV-immune or VV-immune mice than after infection of nonimmune mice (Table 3 ). These results indicate that a prior viral infection can prime a CTL response to a heterologous virus in a subsequent infection.
Priming of CTL Response to Subsequent Acute Viral Infections by Previous Viral
Discussion
This study shows that memory CTL specific to one virus contribute to the primary polyclonal CTL response during infection with a second heterologous virus. This reactivation of memory CTL by heterologous viruses could be due to either (a) a nonspecific stimulation of memory cells, particularly the blast-sized IL-2R-bearing cells, with lymphokines generated during the T cell response to the heterologous virus infection; or (b) a specific stimulation of memory cells due to the fact that they cross-reacted, albeit possibly at a remote level, with MHC-presented heterologous viral or virus-induced cellular peptides. Enhanced expression of adhesion molecules and IL-2R by memory cells might make them particularly sensitive to stimulation by a low affinity T cell antigen. Our data have not ruled out the possibility of substantial levels of nonspecific stimulation, but they do convincingly support the hypothesis of cross-reactivity. This type of cross-reactivity was demonstrated in a number of ways at the clonal level using LDA analyses. (a) Splenic leukocytes from LCMVimmune mice acutely infected with PV or W generated pCTL to LCMV when stimulated in vitro with PEC's infected only with the second virus but not with uninfected PEC's. (b) LCMV-immune splenocytes stimulated in vitro with PV or VV demonstrated a low but significant CTL p/f to the heterologous viruses, and splenocytes from PV-or VV-immune mice when stimulated in vitro against LCMV generated a low but significant p/f to LCMV. (c) LCMV-immune splenocytes stimulated in vitro with an immunodominant LCMV peptide generated a p/f to PV. (d) In short-term LDA cultures using split-well analyses, CTL clones cross-reactive between LCMV and PV were observed in splenic leukocytes from LCMV-immune mice acutdy infected with PV. It should be noted that W and PV were propagated in different calls (L-929) than was LCMV (BHK21), and the fact that the NPpeptide preparation was able to stimulate cross-reactive pCTL in LCMV-immune mice makes it unlikely that a cellular contaminant was the source of the cross-reactivity. In addition, plaque purified stocks of PV and LCMV were tested and found to show the same type of cross-reactivity.
Analyses of the relationships between different viruses and viral proteins have focused on homologies between linear amino add sequences, but cross-reactivities at the level of T cell recognition may not be dependent on a conserved linear sequence of several amino adds. Cross-reactivity in the recognition of unrelated viral peptides by T cell lines and clones has been previously reported (1-4) . Anderson et al. (1) (4) demonstrated that immunization of mice with a W recombinant of the M2 protein of respiratory syncytial virus induced CTL that lysed in a cross-reactive manner targets sensitized with either of two peptides derived from different nonoverlapping regions of the same M2 protein. Analyses of the amino acid sequences of the peptides used in these experiments have showed relatively little homology, and the cross-reactive epitope was often of lower affinity, as defined by the fact that it required much higher concentrations of the peptides to sensitize the target.
Many of the cross-reactive CTL between heterologous viruses in our experiments may be of low affinity to at least one of the viruses. This is supported by the observation that anti-CD8 was more efficient at blocking lysis of the I.CMVinfected target rather than the PV-infected target in LCMVimmune mice acutely infected with PV. It has been reported that blocking with anti-CD8 is one method to differentiate high affinity and low affinity CTL clones (32) . These putatively low affinity cross-reactive interactions may be best observed once a large memory pool has been defined and during an acute infection when activating lymphokines have increased the CTL expression of ancillary adhesion molecules that may enhance the ability of a low affinity interaction to stimulate a T cell expansion.
It is not surprising that processed peptides from different proteins could cross-react, as the presented peptides must comply with the sequence motif for the presenting MHC molecule and therefore may share similar amino acids in two or three critical positions of the peptide nonamer. Numerous virus-spedfic clones recognizing noninfected cells expressing different alleles of class I molecules have also been identified. We have shown high frequencies of LCMV-specific shortterm clones in H-2 b mice that cross-reacted with various different class I MHC alleles, including H-2 k or H-2 d (6).
HSV- (33) and Moloney-spedfic (34) H-2Kb-restricted CTL generated after secondary in vitro stimulation recognize uninfected cells expressing K ~ molecules.
LCMV and PV are both arenaviruses, and they do share considerable amino acid homology, but their serological crossreactivity is nevertheless quite remote. Antisera do not crossneutralize, although there is a report of some cross-reactive complement-fixing antibodies to the viral nucleoprotein (24) and one monodonal antibody directed against a common arenavirus glycoprotein (GP-C) sequence (25) . They share no 9 amino acid sequence overlapping any of the defined LCMV T cell immunodominant peptides, and, in fact, acute PV infection does not generate CTL that can in bulk assays lyse LCMV infected targets, and vice versa ( Figs. 1 and 2 ; reference 12). Our results, however, suggest that some form of CTL cross-reactivity may exist between these two heterologous viruses.
Screening of the published PV NP amino acid sequence revealed at the site of homology with the LCMV NP peptide a nonamer with five amino adds in common with the LCMV H-2b-restricted immunodominant NP LCMV peptide (LCMV --FQPQNGNFI (5); PV = YQPDTGNYI). However, the PV sequence does not have the major fifth position asparagine anchoring amino acid required for binding to the H-2D b motif (5), and we have not been able to show that the synthesized PV peptide can sensitize targets to CTL induced by either PV or I.CMV. This supports the concept that, although LCMV and PV have some amino acid homology, they are heterologous viruses in regards to CTL recognition and do not have similar immunodominant epitopes. The immunodominant epitopes for PV are as yet undefined, and in fact, a search for CTL epitopes on the PV nucleoprotein was unsuccessful (35) . These results also indicate that it may be difficult to predict which viral peptides will be cross-reactive at least until the TCR binding motifs for various viral peptides can be identified. Nevertheless, our data dearly argue that at the level of CTL there is definitely cross-reactivity between LCMV and PV and probably cross-reactivity between LCMV and W, both unexpected findings, as cross-reactivities between these viruses are not seen in conventional hulk assays using CTL from mice infected with a single virus.
The implication of these analyses is that, at the T cell level, there may be a great deal of immunological cross-reactivity between serologically unrelated infectious agents, and by virtue of this proposed remote T cell cross-reactivity, memory T cells from a previous unrelated infection may be reactivated and contribute to the primary response of a putatively unrelated infectious agent. Jones et al. have demonstrated that an MHC-restricted T cell proliferative response to Plasmodium fakiparum malaria antigens could occur in donors not immune to malaria. However, this response required the presence of memory T cells (UCHL1 + cells), suggesting that this cross-reactive response was due to epitopes shared between P. fakiparum and some other common immunogens that induced a memory T cell pool (36) . Cross-reactive memory T cells may account for the high frequency of T cells expressing mRNA for activating lymphokines (IFN-% IL-2) at day 3 early in viral infection long before the primary virus-specific pCTL could have expanded to detectable levels from naive mice (37) . There is evidence in the alloantigen system that naive and memory T cell subsets differ in their ability to synthesize and respond to a variety of cytokines and that each subset can produce cytokines that amplify the response of the other subset (7) . Both subsets appear to be activated to the same extent by alloantigen, and it has been suggested that they synergize in initiating potent responses against transplanted allografts.
These data together suggest that prior immunity to one virus might provide some level of protective natural immunity to an unrelated infectious agent. Consistent with this concept is our previous work showing that VV replication in LCMV-immune mice was reduced by ~10-fold (38), and we have recently found a similar 10-fold reduction of PV titers in LCMV-immune mice, and splenocytes from LCMVimmune mice when transferred to nonimmune recipients (one splenic equivalent/mouse) conferred a similar degree of resistance to FV (data not shown). The mechanism for this resistance to heterologous virus infection has not been clarified, but may involve cross-reactive CD8 + cells, as CD8 + CTL are major regulators of infection for each of these viruses (26, 39) . It is equally feasible that cross-reactivity exists at the CD4 level, and these cells could provide resistance to infection via the secretion of cytokines. These results do, however, suggest that prior immunity to one virus enhances the immune system's ability to handle future viral infections, thereby contributing to natural resistance.
